Human herpesvirus 6 (HHV-6) disease in the setting of transplantation
- 1 August 2012
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 25 (4) , 438-444
Abstract
Human herpesvirus 6 (HHV-6) frequently reactivates after solid-organ and hematopoietic cell transplantation (HCT), and it has been associated with important outcomes in these settings. In 1-2% of recipients or donors, HHV-6 was inherited through chromosomal integration. Although HHV-6 chromosomal integration has not been associated with disease, the resulting very high levels of HHV-6 DNA in human tissue and blood samples can be challenging to interpret in the transplant setting. This review addresses the recent findings regarding the clinical outcomes associated with HHV-6 as well as diagnostic and therapeutic concerns. The evidence supports a causal association between HHV-6 and central nervous system disease. New studies have further characterized the impact of HHV-6 on the central nervous system. In addition, new studies have explored the associations between HHV-6 and other important outcomes. The implications of integrated HHV-6 in transplant recipients remain undefined, though the possibility of an association with organ rejection has been suggested. New exploratory data exist regarding the safety of antiviral prophylactic and preemptive strategies. Our understanding of the full clinical impact of HHV-6 in the transplant population remains incomplete. A large antiviral trial would not only help to further define causality between HHV-6 associated clinical outcomes but also start to define preventive strategies.Keywords
This publication has 68 references indexed in Scilit:
- The Impact of Human Herpesvirus 6B Reactivation on Early Complications following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Quantitative Detection and Differentiation of Human Herpesvirus 6 Subtypes in Bone Marrow Transplant Patients by Using a Single Real-Time Polymerase Chain Reaction AssayTransplantation and Cellular Therapy, 2005
- Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2005
- Impact of human herpesvirus‐6 after haematopoietic stem cell transplantationBritish Journal of Haematology, 2004
- Human Herpesvirus 6 Viremia in Bone Marrow Transplant Recipients: Clinical Features and Risk FactorsThe Journal of Infectious Diseases, 2002
- Human β‐Herpesvirus Interactions in Solid Organ Transplant RecipientsThe Journal of Infectious Diseases, 2001
- High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsBritish Journal of Haematology, 2000
- Human herpesvirus 6 infection after living related liver transplantationJournal of Medical Virology, 2000
- Human Herpesvirus–6 Is Associated with Cytomegalovirus Reactivation in Liver Transplant RecipientsThe Journal of Infectious Diseases, 2000
- Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirusJournal of Medical Virology, 1999